Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.4.3 extracted from

  • Mertlikova-Kaiserova, H.; Rumlova, M.; Tloustova, E.; Prochazkova, E.; Holy, A.; Votruba, I.
    Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG (2011), Biochem. Pharmacol., 82, 131-138.
    View publication on PubMed
Search for more literature for 2.7.4.3

Organism

Organism UniProt Comment Textmining